Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells
- 27 May 2003
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 10 (6), 445-450
- https://doi.org/10.1038/sj.cgt.7700587
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Bax-mediated Ca2+ Mobilization Promotes Cytochrome c Release during ApoptosisPublished by Elsevier BV ,2002
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI Journal of the National Cancer Institute, 2000
- Mitochondrial control of cell deathNature Medicine, 2000
- Molecular characterization of mitochondrial apoptosis-inducing factorNature, 1999
- Movement of Bax from the Cytosol to Mitochondria during ApoptosisThe Journal of cell biology, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.The Journal of Experimental Medicine, 1996
- Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.JCI Insight, 1995
- Comparison of Cellular and Nuclear Flow Cytometric Techniques for Discriminating Apoptotic SubpopulationsExperimental Cell Research, 1994